Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Associated Press - September 24, 2009
PARTICIPANTS: 16,402 HIV-negative Thai men and women ages 18 to 30 at average risk of infection. Half got vaccine and the rest received dummy shots.
WHAT WAS TESTED: A two-vaccine combo, ALVAC-AIDSVAX, from Sanofi Pasteur and the nonprofit Global Solutions for Infectious Diseases.
RESULTS: The vaccine lowered the risk of becoming infected with HIV by more than 31 percent -- a modest benefit that scientists hope to improve.
090924
AP090924
Copyright © 2009 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .